<unk>  is a Monoclonal antibodies that is FDA approved for the treatment of Adjuvant Breast Cancer, Metastatic Breast Cancer, Metastatic Gastric Cancer. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include edema， peripheral edema，tachycardia, rash, weight decreased, abdominal pain，diarrhea，loss of appetite, nausea, stomatitis, vomiting, anemia, neutropenia, thrombocytopenia, infectious disease, breast cancer, arthralgia, backache, myalgia, asthenia, dizziness, headache, insomnia, renal impairment, cough, dyspnea, nasopharyngitis, pharyngitis, rhinitis, upper respiratory infection, fatigue, fever, inflammatory disease of mucous membrane, shivering.
Trastuzumab
Stibine
Tamoxifen
Paclitaxel
Ribociclib
Cetuximab
Zorubicin
Estramustine